Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children

• المؤلفون الرئيسيون: Weerawan Hattasingh (مؤلف), Pornthep Chanthavanich (مؤلف), Chukiat Sirivichayakul (مؤلف), Watcharee Arunsodsai (مؤلف), Surachai Surangsrirat (مؤلف), Termsang Srisuwannaporn (مؤلف), Benjawan Kaewma (مؤلف), Sutee Yoksan (مؤلف), Kriengsak Limkittikul (مؤلف), Junwei Yang (مؤلف), Yu Mao (مؤلف)
• التنسيق: كتاب
• منشور في: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVACTM) was safe and immunogenic in 152 Thai children aged 1-3 years receiving a 2-dose primary...